secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001641172-25-013603
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine shareholders approve reduction in authorized shares from 200M to 75M
-----------------------------------------------------------------------------

- Authorized common stock reduced from 200M to 75M shares; Certificate of Amendment filed June 4, 2025.
- All six director nominees elected: Dr. Mahesh V. Patel, Jeffrey A. Fink, John W. Higuchi, Dr. Jill M. Jene, Dr. Richard Dana Ono, Dr. Spyros Papapetropoulos.
- Tanner LLC ratified as independent auditor for FY 2025 with 2,817,444 votes for, 86,618 against.
- Non-binding advisory vote on executive compensation passed: 926,497 for, 121,032 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000164117225013603/0001641172-25-013603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000164117225013603/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer